Meso-jejunal lymph node dissection has a survival benefit in patients with remnant gastric cancer.
Sung Eun OhMin-Gew ChoiJun Ho LeeTae Sung SohnJae Moon BaeJi Yeong AnPublished in: PloS one (2023)
MJLN dissection should be considered for advanced RGC patients who underwent gastrojejunostomy after distal gastrectomy during their initial surgery according to the index value.
Keyphrases
- end stage renal disease
- minimally invasive
- newly diagnosed
- chronic kidney disease
- ejection fraction
- lymph node
- peritoneal dialysis
- prognostic factors
- coronary artery bypass
- robot assisted
- squamous cell carcinoma
- coronary artery disease
- rectal cancer
- acute coronary syndrome
- sentinel lymph node
- early stage
- free survival